In 2024 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
Treatment Selection Strategies for Metastatic Breast Cancer Patients
Treatment Selection Strategies for Metastatic Breast Cancer Patients
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Poster Pearl: Sacituzumab Govitecan for HR+/HER2- mBC Boosts PFS and OS
Poster Pearl: Sacituzumab Govitecan for HR+/HER2- mBC Boosts PFS and OS
Treating mTNBC: A Safety Analysis of Sacituzumab Govitecan
Treating mTNBC: A Safety Analysis of Sacituzumab Govitecan
news-medical.net
eurekalert.org
esmo.org
hopkinsmedicine.org
clinicaltrialsarena.com
uclahealth.org
